The Israeli IPO Return: eToro, Navan, Via, and the 2026 Pipeline

The Israeli IPO cycle reopened in May 2025 with eToro's $4.3 billion Nasdaq listing, extended through Navan's October listing at $6.2 billion, and continues into 2026 with a defined pipeline. After three years of effectively closed public-markets access for Israeli companies — the 2022 valuation reset, the 2023 banking-sector instability, the post-October 7 risk-premium expansion — the window is open again.

The return is not uniform. eToro priced well and traded well. Navan priced acceptably and traded poorly on debut. Via Transportation slipped from 2025 into the 2026 calendar. The pattern reveals what underwriters and institutional buyers are actually pricing for Israeli technology in 2026.

eToro: the precedent listing

eToro (NASDAQ: ETOR) completed its Nasdaq IPO on May 14, 2025 at a $4.3 billion valuation — substantially below its 2021 SPAC target of $10.4 billion. The book was oversubscribed and the stock traded up materially in the first month. The operative lesson: Israeli technology companies can access public markets, but at materially reset valuations.

Navan: the mid-cycle test

Navan (NASDAQ: NAVN) — corporate travel and expense management, founded by Ariel Cohen and Ilan Twig — went public in October 2025 at $6.2 billion. Priced at the bottom of the marketed range, traded down materially on debut. The cool reception reflected institutional concern about Israeli technology valuations broadly and SaaS multiples specifically, not Navan specifically.

Via Transportation: the 2026 calendar

Via Transportation — mobility platform, founded by Daniel Ramot and Oren Shoval — filed confidentially in 2024 and again in 2025. The 2026 window is the operative target. Where Via prices will define the comparables for the next wave. See also: Via Transportation profile.

The 2026 pipeline

Cato Networks (SASE, ~$350M ARR), XTEND (defense-tech, $1.5B target), Insightec (focused-ultrasound), K Health (AI digital health), and late-stage AI infrastructure names. The defense-tech segment is the structural standout — post-October 7 revenue acceleration is unlike any other category.

What the cycle has tested

Can Israeli companies access US public markets after October 7? Yes. At what valuations? Materially below 2021 peaks — closer to 2017–2019 multiples. Which sectors? Companies with measurable cash-generation profiles and defensible revenue. Pure-growth-narrative listings without near-term economics have not been attempted.